Trade in a Pandemic: Traditional Issues, New Concerns, and Optimal Policy Responses
Featuring Daniel Ikenson, Director, Herbert A. Stiefel Center for Trade Policy Studies; Simon Lester, Associate Director, Herbert A. Stiefel Center for Trade Policy Studies; and Inu Manak, Research Fellow, Herbert A. Stiefel Center for Trade Policy Studies.
During the event, join the conversation and ask questions on Twitter using #CatoTrade. We are also taking questions through Facebook Live and the comment feature on the Cato event webpage. Follow @CatoEvents on Twitter to get future event updates, live streams, and videos from the Cato Institute.
Eliminating trade barriers is essential to the task of containing the COVID-19 pandemic and minimizing its human and economic costs. Yet dozens of governments have imposed restrictions on exports, and others appear to be taking steps toward “repatriating” medical supply chains to achieve self‐sufficiency in critical items. These actions are compounding a time‐to‐market problem caused by preexisting policies such as tariffs on medical goods, divergences between governments in regulatory requirements, and rigid intellectual property protections of medicines and devices.
Please join us for a conversation and learn how the strategic stockpiling of medical supplies, the World Trade Organization and other international bodies, the easing of regulatory restrictions through mutual recognition, and fresh approaches to encouraging medical innovation can all play important roles in the effort to rein in the crisis.
